These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26645895)

  • 1. Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    BMJ; 2015 Dec; 351():h6291. PubMed ID: 26645895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of live attenuated influenza vaccine in atopic children with egg allergy.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    J Allergy Clin Immunol; 2015 Aug; 136(2):376-81. PubMed ID: 25684279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma.
    Turner PJ; Fleming L; Saglani S; Southern J; Andrews NJ; Miller E;
    J Allergy Clin Immunol; 2020 Apr; 145(4):1157-1164.e6. PubMed ID: 31863808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated influenza vaccine for children with egg allergy.
    Greenhawt M
    BMJ; 2015 Dec; 351():h6656. PubMed ID: 26657778
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.
    Daley MF; Clarke CL; Glanz JM; Xu S; Hambidge SJ; Donahue JG; Nordin JD; Klein NP; Jacobsen SJ; Naleway AL; Jackson ML; Lee G; Duffy J; Weintraub E
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):59-68. PubMed ID: 29148124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.
    Pitisuttithum P; Boonnak K; Chamnanchanunt S; Puthavathana P; Luvira V; Lerdsamran H; Kaewkungwal J; Lawpoolsri S; Thanachartwet V; Silachamroon U; Masamae W; Schuetz A; Wirachwong P; Thirapakpoomanunt S; Rudenko L; Sparrow E; Friede M; Kieny MP
    Lancet Infect Dis; 2017 Aug; 17(8):833-842. PubMed ID: 28533093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administering influenza vaccine to egg-allergic persons.
    Kelso JM
    Expert Rev Vaccines; 2014 Aug; 13(8):1049-57. PubMed ID: 24962036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.
    Schuler JE; King WJ; Dayneka NL; Rastelli L; Marquis E; Chad Z; Hui C
    Can J Public Health; 2011; 102(3):196-9. PubMed ID: 21714318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of multidisciplinary resources for vaccination of egg-allergic individuals during an H1N1 (novel) influenza pandemic.
    Pien GC; LeBenger KS; Carotenuto DR; Difilippi M; Scolpino D; Simmons JM; Barrett C; Brenner RW
    Allergy Asthma Proc; 2010; 31(6):507-10. PubMed ID: 20943012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated influenza vaccine use and safety in children and adults with asthma.
    Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF;
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
    de Whalley P; Walker W; Snape MD; Oeser C; Casey M; Moulsdale P; Harrill C; Andrews N; Hoschler K; Thompson B; Jones C; Chalk J; Kerridge S; Tomlinson R; Heath PT; Finn A; Faust S; Miller E; Pollard AJ
    Health Technol Assess; 2011 Dec; 15(45):v-vi, xi-xiii, 1-128. PubMed ID: 22257497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
    Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
    Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
    JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.